Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Pipeline UpdateArcus Biosciences, a clinical-stage biopharmaceutical company focused on developing differentiated molecules and combination therapies for cancer patients, has announce
* This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Arcus Biosciences’s 8K filing here. About Arcus Biosciences (Get Free Report) Arcus Biosciences, Inc, a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company’s pipeline products […]
More Stories
High Gas Prices Could Be the Key Issue That Swings the Senate
By Jeremy Lott Enough voters are fixated on the price of fuel that it could be the deciding issue in...
Treasury Sanctions Iraqi Bank and Iranian Shadow Networks
By Kimberly Hayek The Treasury Department has sanctioned the Iraq-based International Development Bank for Investment and Finance (IDB) and related...
Trump Seeks to Boost Georgia Voters at Rally With Early Voting Underway
By Troy Mters DALTON, Ga.—President Donald Trump, aboard Marine One, flew directly over hundreds of supporters gathered for his rally...
16 Foreign Nationals Charged for Illegal Voting, DOJ Says
By Kimberly Hayek Sixteen foreign nationals in North Carolina, New York, and Idaho, including an illegal immigrant, have been charged...
Renewal Status for Marshals Season 3! Plot, Release Date, and Cast
Luke Grimes is back as everyone’s favourite marshal, Kayce Dutton. The second season of the series is streaming globally, and...
Katie Zacharia Out as Press Secretary, White House Confirms
By Jack Phillips A White House official on Friday told The Epoch Times that new White House press secretary Katie...